GLP-1 receptor agonists help the pancreas release enough insulin, which can result in more insulin being available to lower blood sugar levels in people with type 2 diabetes
Patients experiencing persistent or worsening fatigue should reach out to their healthcare provider
June 26th, 2024: Study reveals GLP-1 drugs may cause bone density loss without exercise A recent study from the University of Copenhagen raises new concerns about GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, highlighting potential bone density loss
Right now, we're offering $100 off your first month, making our already affordable programs even more accessible: GLP-1 just $99 (regularly $199), GLP-2 only $199 (regularly $299), and GLP-3 at $249 (regularly $349)
The PlexusDx Precision Peptide Genetic Test examines these peptide pathway predispositions, helping patients and providers understand genetic background relevant to dosing decisions